BackAnnexin Pharmaceuticals AB Overview

Annexin Pharmaceuticals AB Current Assets

Latest current assets for ANNX.ST: $16M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$16.04M
↓ 57.65% YoYΔ $-21.83M vs prior year quarter

Peer trimmed avg / median

Loading

Annexin Pharmaceuticals AB Current Assets History

Loading

Annexin Pharmaceuticals AB vs. peers: Current Assets Comparison

Loading

Annexin Pharmaceuticals AB Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Annexin Pharmaceuticals AB (ANNX.ST) FAQ

The latest current assets for ANNX.ST is $16M as of September 2026. That compares with $38M in the prior-year period — down 57.7% year over year. Investors often review this figure alongside Annexin Pharmaceuticals AB's historical trend and sector peers before judging valuation or financial health.

Over the past year, ANNX.ST's current assets moved from $38M to $16M — a 57.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Annexin Pharmaceuticals AB's operating scale or balance-sheet position.

A current assets figure of $16M for ANNX.ST is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ANNX.ST's current assets ($16M), review year-over-year change from $38M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Annexin Pharmaceuticals AB's current assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.